SFCM
CGON icon

Seven Fleet Capital Management’s CG Oncology CGON Stock Holding History

Seven Fleet Capital Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.13M Sell
75,758
-1,439,393
-95% -$81.6M 1.61% 14
2025
Q4 		$62.9M Buy
+1,515,151
New +$62.7M 42.57% 1

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Seven Fleet Capital Management's CGON Position: Q1 2026 in Review

Seven Fleet Capital Management reduced its CG Oncology (CGON) stake by 95% in Q1 2026, selling an estimated $81.6M and leaving 75,758 shares worth $5.13M. The position accounts for 1.61% of the portfolio, ranked #14.

Seven Fleet Capital Management first reported a position in CGON in Q4 2025 and has held it in 2 quarters since. The position peaked at $62.9M in Q4 2025. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Seven Fleet Capital Management held 75,758 shares of CG Oncology worth $5.13M as of Q1 2026.
  • Seven Fleet Capital Management sold 1,439,393 CG Oncology shares in Q1 2026, an estimated $81.6M.
  • CG Oncology made up 1.61% of Seven Fleet Capital Management's portfolio in Q1 2026, its #14 holding.
  • Seven Fleet Capital Management first reported a position in CG Oncology in Q4 2025 and has held it in 2 quarters since.
  • Seven Fleet Capital Management's CG Oncology position peaked at $62.9M in Q4 2025.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.